+39 331 386 7522 info@isheo.com

Blog & News

Webinar: Market Access in Italy

Are you looking to launch a new drug in Italy?๐Ÿ’Š ๐Ÿ‡ฎ๐Ÿ‡น When deciding to enter Italy, realise that there not a single health system but many small health systems, each requiring a detailed market entry strategy. Our article shares insight into Market Access in Italy!

Evolving Landscape ATMPs

Evolving Landscape ATMPs

This article explores the evolving landscape of Market Access for Advanced Therapy Medicinal Products (AMTPs).

Patient Registries For Cell And Gene Therapies

Patient Registries For Cell And Gene Therapies

Patient registries are the backbone of clinical research and development. This article explains how they are essential in understanding how individual therapies work and getting them approved by regulatory agencies, especially for Cell and Gene Therapies. What is a...

Multi-Disciplinary Discussion & Patient Diagnosis

Multi-Disciplinary Discussion & Patient Diagnosis

 In this blog post, we discuss the role of multidisciplinary discussion in the early diagnosis of Interstitial lung disease in patients with Autoimmune Rheumatic Diseases. From doctors to therapists, the use of a multitude of professionals is essential when it comes...

Market Access Strategies for ATMPs

Market Access Strategies for ATMPs

What is Market Access? Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment ultimately survives the long process of getting approval to go to the market, there is still no guarantee that that treatment will reach...

Discrete Choice Experiments for Market Access

Discrete Choice Experiments for Market Access

What is Market Access? When learning how to use Discrete Choice Experiments, first we have to look at the bigger picture. Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment finally survived the long and tedious...

ATMPs & Patient Awareness

ATMPs & Patient Awareness

Webinar ATMPs & Patient AwarenessLearn about patient's awareness for ATMPs and challenges in evidence generation. Our experts discuss the most recent evidence on patient's and public perspectives, barriers to engagement and evaluation of patients' experience....

Evidence Synthesis in the EU

Evidence Synthesis in the EU

In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of uncertainty created by the vast set of studies present today. Together,...